Validation, Commissioning & Design Featured Articles
-
AI Agents: The Scientists' New Allies
3/24/2026
AI agents are reshaping biopharma research, offering new ways to analyze data. Find out how success depends on strong data foundations, governance, and thoughtful adoption strategies.
-
Rethinking Design, Cost, And Scalability In Biomanufacturing
3/24/2026
Life science teams increasingly need tools that scale, simplify workflows, and reduce operational costs. Examine how emerging instrumentation focuses on usability, performance, and manufacturability.
-
The Evolution Of Parenteral Manufacturing For Sensitive Drugs
3/23/2026
Parenteral manufacturing is advancing with better facilities, single‑use systems, continuous processing, and Annex 1 compliance to meet demand for specialised biologics and personalised therapies.
-
Quality Over Checkbox Compliance: From QRM To Quality Maturity
3/23/2026
Quality maturity shifts asset management from compliance-focused to risk-based. Discover how performance-driven calibration and leading indicators create systems where quality outcomes become inevitable.
-
5 Costly Consequences Of FDA Non-Compliance
3/23/2026
See how automated maintenance systems help pharma manufacturers avoid FDA citations, preserve client relationships, and build the documented reliability that wins competitive contracts.
-
Managing Compliance Risks With Cloud-Native EAM/CMMS
3/23/2026
What separates systems that maintain compliance effortlessly from those that struggle? Test mobile offline signatures, automated OOT workflows, and integration traceability during vendor evaluations.
-
FDA's CSA Guidance Is Final: What It Means For Your Validation Strategy
3/23/2026
Understand the FDA's shift from rigid CSV to risk-based software assurance. Binary risk classification and flexible testing approaches reduce validation timelines for production and quality.
-
Choosing 21 CFR Part 11 Software: A Practical Buyer's Guide
3/23/2026
Electronic records require audit trails, two-component signatures, authority checks, and ALCOA+ controls. See how to evaluate Part 11 software, build validation packages, and maintain inspection readiness.
-
The Complete Guide To Computer System Validation
3/23/2026
Understand the three-phase validation protocol that proves computer systems meet FDA requirements for accuracy, security, and reliability under 21 CFR Part 11 compliance standards.
-
Unifying EAM And ERP: Transform Asset Management In Life Sciences
3/23/2026
Fragmented systems create compliance risks and operational inefficiencies. Learn how integrated asset management and ERP platforms eliminate duplicate work while maintaining audit-ready documentation.